Estrella Immunopharma (ESLA) filed a registration statement Monday for a secondary offering of more than 2.5 million common shares by selling stockholders.
The company said it will not receive any proceeds from the offering.
Shares of Estrella fell more than 1% in recent trading Monday.
Price: 1.66, Change: -0.03, Percent Change: -1.78